Income Taxes (Tables)
|
12 Months Ended |
Dec. 31, 2025 |
| Income Tax Disclosure [Abstract] |
|
| Schedule of Income before Income Tax, German and Overseas |
The components of loss from continuing operations before income taxes and loss from equity method investments by tax jurisdiction for the year ended December 31, 2025 is as follows (in thousands):
|
|
|
|
|
|
|
Year Ended December 31, 2025 |
|
United States |
|
$ |
(64,645 |
) |
Foreign |
|
|
(595,204 |
) |
Total loss before income taxes and loss from equity method investments |
|
$ |
(659,849 |
) |
The components of loss from continuing operations before income taxes and loss from equity method investments by tax jurisdiction for the year ended December 31, 2024 was as follows (in thousands):
|
|
|
|
|
|
|
Year Ended December 31, 2024 |
|
Germany |
|
$ |
(95,551 |
) |
International |
|
|
(52,854 |
) |
Total loss before income taxes and loss from equity method investments |
|
$ |
(148,405 |
) |
Total
|
| Schedule of Components of Income Tax (Provision) Benefit |
The total tax provision for income taxes for the year ended December 31, 2025 consists of the following (in thousands):
|
|
|
|
|
Year Ended December 31, 2025 |
|
Current benefit from (provision for) income taxes: |
|
|
United States |
$ |
(15 |
) |
United States State & Local |
|
(147 |
) |
International |
|
(136 |
) |
Total current benefit from (provision for) income taxes |
$ |
(298 |
) |
Deferred income tax benefit (provision): |
|
|
United States |
$ |
— |
|
United States State & Local |
|
— |
|
International |
|
— |
|
Total deferred income tax benefit (provision) |
$ |
— |
|
Total income tax benefit (provision): |
|
|
United States |
$ |
(15 |
) |
United States State & Local |
|
(147 |
) |
International |
|
(136 |
) |
Total income tax benefit (provision) |
$ |
(298 |
) |
The total tax benefit from income taxes for the year ended December 31, 2024 consists of the following (in thousands):
|
|
|
|
|
Year Ended December 31, 2024 |
|
Current benefit from (provision for) income taxes: |
|
|
Germany |
$ |
— |
|
International |
|
356 |
|
Total current benefit from (provision for) income taxes: |
$ |
356 |
|
Deferred income tax benefit (provision): |
|
|
Germany |
$ |
— |
|
International |
|
— |
|
Total deferred income tax benefit (provision) |
$ |
— |
|
Total income tax benefit (provision): |
|
|
Germany |
$ |
— |
|
International |
|
356 |
|
Total income tax benefit (provision) |
$ |
356 |
|
|
| Schedule of Effective Income Tax Rate Reconciliation |
A reconciliation of the statutory income tax rate to the Company’s effective income tax rate for continuing operations for the year ended December 31, 2025, after the adoption of ASU 2023-09 as described in Note 2, Basis of Presentation, Consolidation and Summary of Significant Accounting Policies, is as follows (in thousands, except percentages):
|
|
|
|
|
|
|
Year Ended December 31, 2025 |
|
Amount |
|
|
Percent |
U.S federal statutory tax rate: |
$ |
(138,572 |
) |
|
21.00% |
|
|
|
|
|
State and local income tax, net of national income tax effect* |
|
141 |
|
|
(0.02)% |
International tax effects: |
|
|
|
|
Germany: |
|
|
|
|
Statutory tax rate difference |
|
(1,529 |
) |
|
0.23% |
Changes in valuation allowances |
|
(22,485 |
) |
|
3.41% |
Effect of change of domicile |
|
27,581 |
|
|
(4.18)% |
Other |
|
(1,585 |
) |
|
0.24% |
Canada: |
|
|
|
|
Changes in valuation allowances |
|
(454 |
) |
|
0.07% |
Deferred tax adjustments |
|
572 |
|
|
(0.09)% |
Other |
|
14 |
|
|
(0.00)% |
United Kingdom: |
|
|
|
|
Statutory tax rate difference |
|
(21,050 |
) |
|
3.19% |
Changes in valuation allowances |
|
16,814 |
|
|
(2.55)% |
Non-deductible in-process research and development |
|
131,750 |
|
|
(19.97)% |
Effect of deferred tax adjustments |
|
(15,869 |
) |
|
2.40% |
Other |
|
(1,007 |
) |
|
0.15% |
Netherlands: |
|
|
|
|
Changes in valuation allowances |
|
747 |
|
|
(0.11)% |
Other |
|
9,993 |
|
|
(1.51)% |
Other international jurisdictions |
|
123 |
|
|
(0.02)% |
Changes in valuation allowances |
|
9,981 |
|
|
(1.51)% |
Nontaxable or Nondeductible Items: |
|
|
|
|
Effect of deferred tax adjustments |
|
3,276 |
|
|
(0.50)% |
Other |
|
341 |
|
|
(0.05)% |
Changes in unrecognized tax benefits |
|
1,517 |
|
|
(0.23)% |
Total income tax expense |
$ |
298 |
|
|
(0.05)% |
*California, New York State, and New York City make up the majority (greater than 50%) of the tax effect in this category A reconciliation of the statutory income tax rate to the Company’s effective income tax rate for continuing operations for the year ended December 31, 2024, prior to the adoption of ASU 2023-09 as described in Note 2, Basis of Presentation, Consolidation and Summary of Significant Accounting Policies, is as follows (in thousands, except percentages):
|
|
|
|
|
|
|
Year Ended December 31, 2024 |
|
Loss before income taxes: |
|
|
|
Germany |
|
$ |
(96,160 |
) |
International |
|
|
(52,245 |
) |
Total loss before income taxes: |
|
|
(148,405 |
) |
German statutory rate |
|
|
30.18 |
% |
Expected income tax expense (benefit) |
|
|
(44,781 |
) |
|
|
|
|
US state income taxes, net of US federal tax benefit |
|
$ |
(1,010 |
) |
International tax rate differential |
|
|
4,589 |
|
Effect of Australian R&D tax credit incentives |
|
|
(134 |
) |
Effect of consolidation and deconsolidation of subsidiaries |
|
|
88 |
|
Effect of share-based compensation expense |
|
|
305 |
|
Compensation expenses not deductible under IRC Section 162(m) |
|
|
975 |
|
Expenses not deductible for tax purposes |
|
|
525 |
|
Return to provision and deferred tax adjustments |
|
|
(10,438 |
) |
Uncertain Tax Positions |
|
|
(22 |
) |
Change in German and International valuation allowance |
|
|
49,547 |
|
Total income tax expense |
|
$ |
(356 |
) |
|
|
|
|
Effective income tax rate: |
|
|
0.25 |
% |
|
| Schedule of Income Tax Paid |
Upon adoption of ASU 2023-09 as described in Note 2, Basis of Presentation, Consolidation and Summary of Significant Accounting Policies, cash paid for income taxes, net of refunds, during the year ended December 31, 2025 was as follows:
|
|
|
|
|
Year Ended December 31, 2025 |
|
Income taxes paid |
|
|
United States |
$ |
89 |
|
United States State & Local |
|
286 |
|
Foreign |
|
214 |
|
Total income taxes paid |
$ |
589 |
|
Income taxes paid (net of refunds) exceeded 5 percent of total income taxes paid (net of refunds) in the following jurisdictions:
|
|
|
|
|
|
|
|
Year Ended December 31, 2025 |
|
United States - States & Local |
|
|
New York |
$ |
120 |
|
New York City |
|
107 |
|
|
|
|
Foreign |
|
|
United Kingdom |
$ |
214 |
|
|
| Schedule of Components of Deferred Tax Assets and Deferred Tax Liabilities |
Significant components of deferred tax assets and deferred tax liabilities consisted of the following for the year ended December 31, 2025 (in thousands):
|
|
|
|
|
|
|
Year Ended December 31, 2025 |
|
Deferred tax assets: |
|
|
|
U.S tax loss carryforwards |
|
$ |
27,740 |
|
Foreign tax loss carryforwards |
|
|
65,756 |
|
Share compensation |
|
|
31,428 |
|
Capitalized research and experimentation expenses |
|
|
39,023 |
|
Other deductible timing differences |
|
|
1,494 |
|
Total deferred tax assets, gross |
|
|
165,441 |
|
Valuation allowance |
|
|
(147,624 |
) |
Total deferred tax assets, net |
|
$ |
17,817 |
|
|
|
|
|
Deferred tax liabilities: |
|
|
|
Fixed and intangible assets |
|
$ |
(1,513 |
) |
Unrealized foreign exchange |
|
|
(5,217 |
) |
Outside basis differences in equity and other investments |
|
|
(3,299 |
) |
Investments |
|
|
(7,765 |
) |
Other timing differences |
|
|
(23 |
) |
Total deferred tax liabilities |
|
|
(17,817 |
) |
Total deferred tax asset (liability) |
|
$ |
— |
|
Significant components of deferred tax assets and deferred tax liabilities consisted of the following for the year ended December 31, 2024 (in thousands):
|
|
|
|
|
|
|
Year Ended December 31, 2024 |
|
Deferred tax assets: |
|
|
|
German tax loss carryforwards |
|
$ |
55,507 |
|
International tax loss carryforwards |
|
|
26,869 |
|
Share compensation |
|
|
39,975 |
|
Capitalized research and experimentation expenses |
|
|
31,010 |
|
Other deductible timing differences |
|
|
1,300 |
|
Total deferred tax assets, gross |
|
|
154,661 |
|
Valuation allowance |
|
|
(139,514 |
) |
Total deferred tax assets, net |
|
$ |
15,147 |
|
|
|
|
|
Deferred tax liabilities: |
|
|
|
Fixed and intangible assets |
|
$ |
(1,626 |
) |
Unrealized foreign exchange |
|
|
(6,571 |
) |
Outside basis differences in equity and other investments |
|
|
(2 |
) |
Investments |
|
|
(6,948 |
) |
Total deferred tax liabilities |
|
|
(15,147 |
) |
Total deferred tax asset (liability) |
|
$ |
— |
|
|
| Schedule of Gross Tax Loss Carryforward for Tax Return Purpose |
The Company’s gross tax loss carryforward for tax return purposes are as follows for the year ended December 31, 2025 (in thousands):
|
|
|
|
|
|
|
Year Ended December 31, 2025 |
|
U.S. tax losses |
|
$ |
99,701 |
|
Foreign tax losses |
|
|
232,357 |
|
Total |
|
$ |
332,058 |
|
The Company’s gross tax loss carryforward for tax return purposes are as follows for the year ended December 31, 2024 (in thousands):
|
|
|
|
|
|
|
Year Ended December 31, 2024 |
|
Germany tax losses |
|
$ |
183,952 |
|
International tax losses |
|
|
97,985 |
|
Total |
|
$ |
281,937 |
|
|
| Schedule of Unrecognized Tax Benefits |
As of December 31, 2025 and 2024, the Company notes the following unrecognized tax benefits (in thousands).
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, |
|
|
|
2025 |
|
|
2024 |
|
Balance as of December 31, 2024 |
|
$ |
— |
|
|
$ |
369 |
|
Increases—prior year tax positions |
|
|
1,517 |
|
|
|
— |
|
Decreases—prior year tax positions |
|
|
— |
|
|
|
(369 |
) |
Increases—current year tax positions |
|
|
|
|
|
— |
|
Balance as of December 31, 2025 |
|
$ |
1,517 |
|
|
$ |
— |
|
|